| ST4SA | Enterococcus mundtii | IIa | |
| Bacillocin 602 | Paenibacillus polymyxa NRRL B-30509 | IIa | | Gastrointestinal tract infections | Campylobacter infection | in-vivo (Chickens model /Turkey model) | Cole et al. 2006 | | Gastrointestinal tract infections | Campylobacter infection | in-vivo (Chickens model /Turkey model) | Stern et al. 2005 | | Hospital-acquired infections | Multi drug resistant strain | in-vitro | Svetoch et al. 2009 |
|
| E 50-52 | Enterococcus faecium NRRL B-30746 | IIa | |
| L-1077 | Lactobacillus salivarius NRRL B-50053 | IIa | | Gastrointestinal tract infections | Stomach and intestine infections | - in-vitro
- in-situ (chicken model)
| Svetoch et al. 2011 |
|
| Enterocin 96 | Enterococcus faecalis WHE96 | II | |